Sunil Godhwani responsible for Group’s woes: Singh Brothers

NEW DELHI: Former promoters of Fortis Healthcare and Religare Malvinder Singh and Shivinder Singh today blamed former Religare Enterprises Chairman and Managing Director Sunil Godhwani for the group’s troubles.

“The Group’s troubles today stem from the Group’s association with Sunil Godhwani who had started his association in Religare as its CEO in 2001,” Malvinder Singh and Shivinder Singh said in a joint statement.

Godhwani had stepped down as the chairman and MD in July 29, 2016. Subsequently, he assumed charge of the CEO in Religare Enterprises.

After the Ranbaxy sale closed in 2008, it was decided that Godhwani will lead our family office in addition to his role in Religare, and from 2008-end, he had full management control of RHC Holding and its subsidiaries, it added.

He was expected to be a responsible trustee and steward of the family’s resources and consequently our reputation, the statement said.

“Godhwani used his position to conceive and orchestrate a series of transactions over the better part of a decade that led to our Group’s debt load by 2016,” it added.

It is clear that he used our trust in him to exercise undue influence and has taken advantage of the faith bestowed by both families, the statement said.

“We are sure (Gurinder Singh) Dhillon and his family would have had a similar expectation from Godhwani regarding management of their resources,” it added.

Gurinder Singh Dhillon is the spiritual guru of the Radha Soami Satsang Beas (RSSB).

  • Related Posts

    Lilly launches Mounjaro KwikPen in India

    Mumbai, August 14, 2025 — Eli Lilly and Company (India) has rolled out the Mounjaro (tirzepatide) KwikPen across the country, expanding treatment choices for people with type-2 diabetes and those…

    Fortis Q1 Profit Jumps 57%; Expansion Drives Growth

      Gurugram, August 7 – http://Fortis HealthcareFortis Healthcare has reported a 57% year-on-year increase in its net profit for the first quarter of FY2025. The hospital chain posted ₹260 crore…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Supreme Court declines plea to make nucleic acid tests compulsory at blood banks

    Supreme Court declines plea to make nucleic acid tests compulsory at blood banks

    Jaipur: Fraudster Arun Kumar Arrested for Extorting Medical Store Owners by Posing as Drug Inspector

    Jaipur: Fraudster Arun Kumar Arrested for Extorting Medical Store Owners by Posing as Drug Inspector

    India’s Medical Devices Sector Logs 4,108 Licensed Manufacturers and ₹20,658 Crore FDI Inflows Since 2018

    India’s Medical Devices Sector Logs 4,108 Licensed Manufacturers and ₹20,658 Crore FDI Inflows Since 2018

    Abbott introduces its most advanced drug eluting stent XIENCE Skypoint™ in India

    Abbott introduces its most advanced drug eluting stent XIENCE Skypoint™ in India

    Top 30 pharma companies post 12% revenue growth in first nine months

    Top 30 pharma companies post 12% revenue growth in first nine months

    India Cracks Down On Ads For Weight-Loss Drugs Like GLP-1 In New Advisory

    India Cracks Down On Ads For Weight-Loss Drugs Like GLP-1 In New Advisory